Tao, Yungan <br/><br/>
A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma.  [electronic resource] 

 -  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology  Jan 2011 
 - 42-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1879-0887 
<br/><br/><label>Standard No.: </label>10.1016/j.radonc.2010.11.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Carcinoma--drug therapy<br/>Carcinoma, Squamous Cell<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Female<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Neoplasms, Squamous Cell--drug therapy<br/>Radiotherapy Dosage<br/>Squamous Cell Carcinoma of Head and Neck